PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.

Also called NCT06915792

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 110 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06915792
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06915792. Randomized; no masking; primary purpose treatment. Start 2025-06-01 (actual); primary completion 2027-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
Acronym
PEACE
Condition
Postpartum Hypertension (PPHT)
Intervention (Drug)
Labetalol
Intervention (Drug)
Nifedipine
Lead sponsor
University of California, Los Angeles (class: other)

Record details

Record id
cardio:ct-nct06915792
Content hash
605af11a1395f842d7432465c142a57a6b7f0f2c0471618f3238dd785765fbb1